Murray Abramson, MD, MPH
Senior Vice President Head of Clinical Development
Murray Abramson, MD, MPH Is Senior Vice President, Head of Clinical Development and will oversee all clinical, safety, and medical affairs activities including clinical and operational strategy for our lead PBGENE-HBV program, as well as for the Company’s other portfolio assets. Dr. Abramson is a medical internist and infectious diseases/public health specialist with extensive drug development expertise. Dr Abramson was most recently the Senior Vice President, clinical innovation at Tempus A.I. following his nine years as Vice President of Global Clinical Operations at Biogen. Dr. Abramson also spent over twelve years at Merck in medical and medical research operations roles. Prior to joining Merck, Dr. Abramson was a faculty member at Duke University School of Medicine and Director, Infectious Diseases Clinical Research at Duke Clinical Research Institute. Dr. Abramson received his Medical Degree at Duke University Medical Center and his Master of Public Health degree in Epidemiology from the University of North Carolina at Chapel Hill.